THNR vs. CWS ETF Comparison

Comparison of Amplify Weight Loss Drug & Treatment ETF (THNR) to AdvisorShares Focused Equity ETF (CWS)
THNR

Amplify Weight Loss Drug & Treatment ETF

THNR Description

The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$26.35

Average Daily Volume

2,962

Number of Holdings *

6

* may have additional holdings in another (foreign) market
CWS

AdvisorShares Focused Equity ETF

CWS Description The AdvisorShares Focused Equity ETF seeks long-term capital appreciation. CWS aims to achieve its investment objective by investing primarily in a focused group of U.S. exchange-listed equity securities that the portfolio manager believes have favorable fundamental attributes.

Grade (RS Rating)

Last Trade

$68.39

Average Daily Volume

9,535

Number of Holdings *

25

* may have additional holdings in another (foreign) market
Performance
Period THNR CWS
30 Days -4.50% 2.06%
60 Days 3.71% 7.63%
90 Days 0.30% 9.64%
12 Months 33.60%
1 Overlapping Holdings
Symbol Grade Weight in THNR Weight in CWS Overlap
TMO D 4.91% 3.98% 3.98%
THNR Overweight 5 Positions Relative to CWS
Symbol Grade Weight
LLY D 14.78%
NVO F 12.82%
AZN D 7.38%
AMGN D 5.12%
PFE D 4.78%
THNR Underweight 24 Positions Relative to CWS
Symbol Grade Weight
FICO C -5.69%
HEI C -5.0%
MLR B -4.9%
AFL A -4.74%
FI A -4.64%
APH D -4.47%
ICE A -4.31%
MCO D -4.16%
SYK C -4.13%
ROL C -3.97%
OTIS A -3.96%
SLGN B -3.92%
AWK D -3.82%
SAIC A -3.81%
COR F -3.79%
BR B -3.63%
HSY D -3.57%
ABT C -3.57%
INTU F -3.41%
FDS C -3.34%
AGM D -3.33%
PII D -3.01%
MGRC D -3.01%
CE D -3.0%
Compare ETFs